US Stock MarketDetailed Quotes

COGT Cogent Biosciences

Watchlist
  • 7.840
  • +0.040+0.51%
Close Dec 20 16:00 ET
  • 7.840
  • 0.0000.00%
Post 17:22 ET
866.02MMarket Cap-3.16P/E (TTM)

Cogent Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-36.90%-51.98M
-33.17%-42.7M
-32.93%-52.53M
-29.49%-153.62M
-49.86%-44.07M
-10.25%-37.97M
-21.21%-32.07M
-39.47%-39.52M
-101.89%-118.64M
-41.54%-29.41M
Net income from continuing operations
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
Operating gains losses
----
----
----
--8K
----
----
----
----
----
----
Depreciation and amortization
28.30%1.1M
-11.18%1.08M
47.44%1.07M
-38.96%3.59M
-15.26%794K
-76.96%855K
81.49%1.22M
29.11%723K
195.23%5.88M
71.61%937K
Other non cash items
----
----
----
-25.00%-1.7M
--0
--0
--0
---1.7M
-296.50%-1.36M
----
Change In working capital
94.41%13.4M
-41.03%2.58M
31.85%-3.24M
1,423.57%11.44M
-27.06%4.94M
200.45%6.89M
33.70%4.37M
-95.48%-4.76M
326.70%751K
2,677.19%6.78M
-Change in prepaid assets
141.63%746K
-60.43%-592K
-248.73%-1.1M
57.87%-626K
13.35%1.85M
18.91%-1.79M
-114.53%-369K
57.12%-316K
-554.63%-1.49M
-2.04%1.63M
-Change in payables and accrued expense
45.18%13M
-27.51%3.51M
57.18%-1.81M
8.69%12.98M
-38.51%3.42M
179.12%8.96M
97.39%4.84M
-678.25%-4.23M
93.22%11.95M
1,770.03%5.55M
-Change in other current assets
--0
--0
93.33%-2K
88.31%-119K
-108.70%-2K
-168.50%-87K
--0
98.40%-30K
72.69%-1.02M
101.36%23K
-Change in other current liabilities
-88.83%-355K
-235.64%-339K
-76.47%-330K
90.84%-796K
25.93%-320K
97.65%-188K
-136.46%-101K
66.00%-187K
-323.49%-8.69M
19.40%-432K
Cash from discontinued investing activities
Operating cash flow
-36.90%-51.98M
-33.17%-42.7M
-32.93%-52.53M
-29.49%-153.62M
-49.86%-44.07M
-10.25%-37.97M
-21.21%-32.07M
-39.47%-39.52M
-101.89%-118.64M
-41.54%-29.41M
Investing cash flow
Cash flow from continuing investing activities
166.48%60.19M
-8.97%-84.63M
-98.26%1.04M
21.56%-97.82M
-63.08%10.49M
40.26%-90.54M
-6,688.55%-77.66M
13,679.14%59.88M
-7,155.26%-124.72M
6,661.43%28.41M
Net PPE purchase and sale
-131.40%-280K
88.23%-148K
93.65%-70K
59.26%-2.8M
83.99%-315K
96.35%-121K
-9.88%-1.26M
-150.11%-1.1M
-299.24%-6.86M
-354.27%-1.97M
Net investment purchase and sale
166.88%60.47M
-10.57%-84.48M
-98.17%1.11M
19.37%-95.03M
-64.43%10.8M
39.00%-90.42M
---76.4M
--60.99M
---117.86M
--30.38M
Cash from discontinued investing activities
Investing cash flow
166.48%60.19M
-8.97%-84.63M
-98.26%1.04M
21.56%-97.82M
-63.08%10.49M
40.26%-90.54M
-6,688.55%-77.66M
13,679.14%59.88M
-7,155.26%-124.72M
6,661.43%28.41M
Financing cash flow
Cash flow from continuing financing activities
-37.60%624K
-100.16%-256K
48,002.70%214.06M
-0.01%163.54M
0
1.01%1M
-0.01%162.09M
222.46%445K
330.69%163.56M
-99.17%315K
Net common stock issuance
--0
-100.23%-365K
--213.7M
-0.08%161.82M
--0
0.00%-170K
--161.99M
--0
326.10%161.95M
--0
Proceeds from stock option exercised by employees
-46.67%624K
6.86%109K
-20.00%356K
6.45%1.72M
--0
0.86%1.17M
--102K
222.46%445K
2,832.73%1.61M
--315K
Cash from discontinued financing activities
Financing cash flow
-37.60%624K
-100.16%-256K
48,002.70%214.06M
-0.01%163.54M
--0
1.01%1M
-0.01%162.09M
222.46%445K
330.69%163.56M
-99.17%315K
Net cash flow
Beginning cash position
-58.84%88.22M
33.25%215.8M
-62.29%53.23M
-36.12%141.14M
-38.79%86.81M
-34.42%214.32M
-15.78%161.95M
-36.12%141.14M
-9.24%220.94M
-30.53%141.82M
Current changes in cash
106.92%8.83M
-343.64%-127.58M
681.15%162.57M
-10.17%-87.91M
-4,823.90%-33.58M
31.08%-127.51M
-61.07%52.36M
172.68%20.81M
-254.56%-79.8M
-104.06%-682K
End cash Position
11.79%97.05M
-58.84%88.22M
33.25%215.8M
-62.29%53.23M
-62.29%53.23M
-38.79%86.81M
-34.42%214.32M
-15.78%161.95M
-36.12%141.14M
-36.12%141.14M
Free cash flow
-37.20%-52.26M
-28.59%-42.85M
-29.49%-52.6M
-24.64%-156.42M
-41.47%-44.39M
-0.90%-38.09M
-20.74%-33.32M
-41.16%-40.62M
-107.50%-125.5M
-47.93%-31.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -36.90%-51.98M-33.17%-42.7M-32.93%-52.53M-29.49%-153.62M-49.86%-44.07M-10.25%-37.97M-21.21%-32.07M-39.47%-39.52M-101.89%-118.64M-41.54%-29.41M
Net income from continuing operations -27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M
Operating gains losses --------------8K------------------------
Depreciation and amortization 28.30%1.1M-11.18%1.08M47.44%1.07M-38.96%3.59M-15.26%794K-76.96%855K81.49%1.22M29.11%723K195.23%5.88M71.61%937K
Other non cash items -------------25.00%-1.7M--0--0--0---1.7M-296.50%-1.36M----
Change In working capital 94.41%13.4M-41.03%2.58M31.85%-3.24M1,423.57%11.44M-27.06%4.94M200.45%6.89M33.70%4.37M-95.48%-4.76M326.70%751K2,677.19%6.78M
-Change in prepaid assets 141.63%746K-60.43%-592K-248.73%-1.1M57.87%-626K13.35%1.85M18.91%-1.79M-114.53%-369K57.12%-316K-554.63%-1.49M-2.04%1.63M
-Change in payables and accrued expense 45.18%13M-27.51%3.51M57.18%-1.81M8.69%12.98M-38.51%3.42M179.12%8.96M97.39%4.84M-678.25%-4.23M93.22%11.95M1,770.03%5.55M
-Change in other current assets --0--093.33%-2K88.31%-119K-108.70%-2K-168.50%-87K--098.40%-30K72.69%-1.02M101.36%23K
-Change in other current liabilities -88.83%-355K-235.64%-339K-76.47%-330K90.84%-796K25.93%-320K97.65%-188K-136.46%-101K66.00%-187K-323.49%-8.69M19.40%-432K
Cash from discontinued investing activities
Operating cash flow -36.90%-51.98M-33.17%-42.7M-32.93%-52.53M-29.49%-153.62M-49.86%-44.07M-10.25%-37.97M-21.21%-32.07M-39.47%-39.52M-101.89%-118.64M-41.54%-29.41M
Investing cash flow
Cash flow from continuing investing activities 166.48%60.19M-8.97%-84.63M-98.26%1.04M21.56%-97.82M-63.08%10.49M40.26%-90.54M-6,688.55%-77.66M13,679.14%59.88M-7,155.26%-124.72M6,661.43%28.41M
Net PPE purchase and sale -131.40%-280K88.23%-148K93.65%-70K59.26%-2.8M83.99%-315K96.35%-121K-9.88%-1.26M-150.11%-1.1M-299.24%-6.86M-354.27%-1.97M
Net investment purchase and sale 166.88%60.47M-10.57%-84.48M-98.17%1.11M19.37%-95.03M-64.43%10.8M39.00%-90.42M---76.4M--60.99M---117.86M--30.38M
Cash from discontinued investing activities
Investing cash flow 166.48%60.19M-8.97%-84.63M-98.26%1.04M21.56%-97.82M-63.08%10.49M40.26%-90.54M-6,688.55%-77.66M13,679.14%59.88M-7,155.26%-124.72M6,661.43%28.41M
Financing cash flow
Cash flow from continuing financing activities -37.60%624K-100.16%-256K48,002.70%214.06M-0.01%163.54M01.01%1M-0.01%162.09M222.46%445K330.69%163.56M-99.17%315K
Net common stock issuance --0-100.23%-365K--213.7M-0.08%161.82M--00.00%-170K--161.99M--0326.10%161.95M--0
Proceeds from stock option exercised by employees -46.67%624K6.86%109K-20.00%356K6.45%1.72M--00.86%1.17M--102K222.46%445K2,832.73%1.61M--315K
Cash from discontinued financing activities
Financing cash flow -37.60%624K-100.16%-256K48,002.70%214.06M-0.01%163.54M--01.01%1M-0.01%162.09M222.46%445K330.69%163.56M-99.17%315K
Net cash flow
Beginning cash position -58.84%88.22M33.25%215.8M-62.29%53.23M-36.12%141.14M-38.79%86.81M-34.42%214.32M-15.78%161.95M-36.12%141.14M-9.24%220.94M-30.53%141.82M
Current changes in cash 106.92%8.83M-343.64%-127.58M681.15%162.57M-10.17%-87.91M-4,823.90%-33.58M31.08%-127.51M-61.07%52.36M172.68%20.81M-254.56%-79.8M-104.06%-682K
End cash Position 11.79%97.05M-58.84%88.22M33.25%215.8M-62.29%53.23M-62.29%53.23M-38.79%86.81M-34.42%214.32M-15.78%161.95M-36.12%141.14M-36.12%141.14M
Free cash flow -37.20%-52.26M-28.59%-42.85M-29.49%-52.6M-24.64%-156.42M-41.47%-44.39M-0.90%-38.09M-20.74%-33.32M-41.16%-40.62M-107.50%-125.5M-47.93%-31.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List